PUBLISHED FOR OPPOSITION
on 24 Sep 2024
Last Applicant/ Owned by
Fl3,Bld9, Accelerator Phase 2, Biotech &
Nanjing
CN
210032
Serial Number
97486277 filed on 01st Jul 2022
Registration Number
N/A
Filing Basis
1. intent to use
Disclaimer
NO DATA
TRANSTHERA
Vaccines; Chemical preparations for pharmaceutical or medical purposes, namely, for treatment of cancer, cardiovascular diseases and disorders, metabolic diseases and disorders, anemia and associated anemia diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation, skeletal or chondrocyte d Read More
Classification Information
Class [005]
Pharmaceutical Products
Vaccines; Chemical preparations for pharmaceutical or medical purposes, namely, for treatment of cancer, cardiovascular diseases and disorders, metabolic diseases and disorders, anemia and associated anemia diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation, skeletal or chondrocyte disorders, immune and autoimmune diseases, hematological disorders; Medicines for alleviating constipation; Medicines for intestinal disorders; Medicines for the treatment of cardiovascular and cerebrovascular diseases; Medicines for the treatment of gastrointestinal diseases; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the treatment of cancer, cardiovascular diseases and disorders, metabolic diseases and disorders, anemia and associated anemia diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation, skeletal or chondrocyte disorders, immune and autoimmune diseases, hematological disorders
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 97486277
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 79000.049UST
44D Filed
No
44D Current
No
44E filed
No
44E Current
Yes
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Design Code(s)
05.03.08 -
More than one leaf, including scattered leaves, bunches of leaves not attached to branches
05.03.25 -
Other leaves
26.17.09 -
Curved line(s), band(s) or bar(s)
28.01.03 -
Japanese and Chinese characters Formerly Inscriptions in Chinese, Japanese, Korean, Vietnamese or other Asian characters
Legal History
| Status Date | Action Taken |
|---|---|
| 24th Sep 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 24th Sep 2024 | PUBLISHED FOR OPPOSITION |
| 04th Sep 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 19th Aug 2024 | CASE RETURNED TO EXAMINATION |
| 19th Aug 2024 | NOTICE OF ALLOWANCE CANCELLED |
| 15th Aug 2024 | PETITION TO DIRECTOR - CHANGE BASIS - GRANTED |
| 15th Aug 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 15th Aug 2024 | SOU EXTENSION 2 GRANTED |
| 15th Aug 2024 | ASSIGNED TO PETITION STAFF |
| 15th Aug 2024 | JURISDICTION RESTORED TO EXAMINING ATTORNEY |